Skip to main content
Download PDF

Gene alterations in monocytes are pathogenic factors for immunoglobulin a nephropathy by bioinformatics analysis of microarray data

BMC Nephrology volume 19, Article number: 184 (2018) Cite this article

Abstract

Background

Immunoglobulin A nephropathy (IgAN) is the most frequent primary glomerulopathy worldwide. The study aimed to provide potential molecular biomarkers for IgAN management.

Methods

The public gene expression profiling GSE58539 was utilized, which contained 17 monocytes samples (8 monocytes samples isolated from IgAN patients and 9 monocytes samples isolated from healthy blood donors). Firstly, differentially expressed genes (DEGs) between the two kinds of samples were identified by limma package. Afterwards, pathway enrichment analysis was implemented. Thereafter, protein-protein interaction (PPI) network was constructed and key nodes in PPI network were predicted using four network centrality analyses. Ultimately, gene functional interaction (FI) was constructed according to expressions in each sample, and then module network was extracted from FI network.

Results

A total of 678 DEGs were screened out, of these, 72 DEGs were identified as crucial nodes in PPI network that could well distinguish IgAN and healthy samples. In particular, IL6, TNF, IL1B, PRKACA and CCL20 were closely related to pathways such as hematopoietic cell lineage, apoptosis and Toll-like receptor (TLR) signaling pathway. Moreover, 12 genes in the FI network belonged to the 72 identified key nodes, such as CCL20, HDAC10, FPR2 and PRKACA, which were also key genes in 4 module networks.

Conclusions

Several crucial genes were identified in monocytes of IgAN patients, such as IL6, TNF, IL1B, CCL20, PRKACA, FPR2 and HDAC10. These genes might co-involve in pathways such as TLR and apoptosis signaling during IgAN progression.

Peer Review reports

Background

Worldwide, immunoglobulin A nephropathy (IgAN) is the most frequent primary glomerulopathy. Reportedly, 20–50% of adults who suffered with IgAN would progress to end-stage renal diseases [1]. Therefore, it is pivotal for IgAN patients to identify predictors of prognosis. Numerous risk factors associated with IgAN progression have been reported. A study in Chinese population identifies three risk factors, including renal impairment, hypertension as well as advanced histological involvement [2]. Besides, another study reveals that expressions of renal leukocyte infiltrations and cytokines, such as leukocyte common antigen (LCA), CD3, CD68 and interleukin-1Beta (IL1B), are highly correlated with IgAN [3]. Currently, biochemical and genetic data indicate that aberrantly glycosylated IgA1 play significant roles in pathogenesis of IgAN [4,5,6]. Moreover, alteration on the glycan structure of IgA1 causes the deposition of nephritogenic immune complexes, which induce resident mesangial cells proliferation and extracellular matrix proteins expression, and subsequently lead to the loss of glomerular function [7]. Based on the pathogenesis, several biomarkers have been identified, such as levels of urinary secretory (sIgA) [8], serum galactose-deficient immunoglobulin A1 (Gd-IgA1) [9] and the tandem repeats polymorphism of MUC20 gene [10]. However, cellular events involved in the IgAN pathogenesis are unclear.

Recently, it is found that abnormality of IgAN disease is related to IgA immune system and peripheral blood leucocytes, especially the peripheral blood mononuclear cells [11, 12]. Monocytes, a kind of the phagocytes that formed in bone marrow, can differentiate into macrophages and dendritic cells (DCs) in peripheral tissues. Monocytes have a crucial part in immune response and may contribute to the pathogenesis of IgAN [13]. Thus, a guideline for target therapy of IgAN will be obtained through identifying gene alterations in monocytes of IgAN patients. Moreover, Cox et al. uncover that the altered genes in IgAN monocytes are mainly associated with apoptotic pathway and mitochondrial dysfunction [13]. In particular, the expression of NADH: ubiquinone oxidoreductase core subunit S3 (NDUFS3) and TNF receptor superfamily member 1A (TNFRSF1A) proteins are upregulated, thus verifying the altered mitochondrial respiratory system and death receptor homeostasis. Additionally, the TNF expression in monocytes of IgAN patients are reduced compared with those in healthy blood donors (HBDs) [13]. However, other critical genes and their interaction have not been investigated.

In the present study, we re-analyzed GSE58539 profiling using a more comprehensive bioinformatics. After identifying the differentially expressed genes (DEGs) in monocytes between IgAN patients and HBDs, functional enrichment and protein-protein interactions (PPIs) network analyses were carried out, followed by key nodes prediction of the network through four network centrality analyses. Notably, in order to reveal potential interactions of DEGs that involved in similar functions and pathways, gene functional interaction (FI) network and the module network analyses were performed based on gene expressions of each sample. The study aimed to further uncover the pathogenesis and progression of IgAN, and thus provide potential molecular biomarkers for the diagnosis and targeting therapy of IgAN.

Methods

Data resource

The microarray data GSE58539 [13] was downloaded from Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo) database. This dataset contained 17 monocytes samples, including 8 monocytes samples isolated from IgAN patients (IgAN group) and 9 monocytes samples isolated from HBDs (healthy group). The platform of the dataset was Illumina HumanHT-12 V4.0 expression beadchip (Illumina, San Diego, California, USA).

Data preprocessing

We used the robust multi-array average (RMA) method in Linear Models for Microarray Analysis (limma, http://www.bioconductor.org/packages/release/bioc/html/limma.html) package of R [14] to preprocess the non-normalized raw data by performing background correction, quantile normalization and microarray data condensation. Afterwards, the probe identification numbers (IDs) were transformed into gene symbols utilizing illuminaHumanv4.db [15] and annotate [16] software in R package and the probes were eliminated which did not correspond to gene symbols. Finally, the average value of different probes would serve as the final expression of the gene if different probes were mapped to the same gene.

DEGs identification

Non-paired t-test method in limma package was utilized to calculate significance p-value of the DEGs between IgAN and healthy samples. The thresholds for DEG selection were p-value < 0.05 and log2|fold change| ≥ 0.58. Subsequently, coupled two-way clustering analysis (CTWC) was conducted using gplots tools [17] in R package.

Enrichment analysis of the DEGs

The Database for Annotation, Visualization and Integration Discovery (DAVID, http://david.abcc.Ncifcrf.gov/) [18] tool was used to conduct Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.genome.jp/kegg/pathway.html) [19] pathway enrichment analyses for DEGs. The number of enrichment genes (count number) ≥ 2 and p-value < 0.05 were chosen as cut-off criteria.

Construction of the PPI network

The Search Tool for the Retrieval of Interacting Genes (STRING, http://string-db.org/) [20] database was used to predict potential interactions among proteins encoded by the DEGs. Relevant parameters were as follows: species was “Homo”, the input genes were DEGs and the PPI score (referred to medium confidence) was set as 0.4. A protein in the PPI network serves as a node. The network was visualized by the Cytoscape (http://cytoscape.org/) software [21].

Prediction of key nodes in the PPI network

The topological property of PPI network makes it possible to investigate key genes in the network. Here, four network centrality analyses were performed to explore the key genes, including degree centrality, betweenness centrality, subgraph centrality and closeness centrality of key genes. Generally, degree was used for describing the importance of protein nodes in the network, and betweenness centrality is a kind of indicator that describes the global topological properties of the network. Besides, subgraph centrality was used to measure the importance of nodes in the network based on the combination of network topology and protein complex information. Closely centricity represented the closely connection degree of a certain node and all other nodes [22,23,24,25].

A cytoscape plug-in, CytoNCA [26], was used to perform the above analyses. Nodes with high values in the above four network centrality analyses were screened out to predict key genes, and the genes influence on sample clustering were observed using gplots packages. Detailed steps for the selection of key genes were: (1) the top ten genes with high values calculated by each network centrality analysis were selected and then were integrated; (2) if these integrated genes could not well distinguish the IgAN and healthy samples, more nodes were gradationally selected based on their ranked values to conduct the clustering analysis till they could distinguish completely the two kinds of samples. These key genes were then defined as feature genes of IgAN and healthy samples.

FI network analysis

Based on gene expression value of each sample, the gene FI network was established using Cytoscape app-ReactomeFI [27]. The input dataset was the expression matrix of all DEGs. The FI network was analyzed utilizing ReactomeFI and the gene functional interaction in the PATHWAY of the Reactome database, thereafter modules from the FI network were obtained through Monte Carlo Localization clustering algorithm [28]. In addition, co-expression relationships of genes in each module were determined according to their expression value. The selection parameters in ReactomeFI network were module size ≥7 and average correlation ≥0.25. Subsequently, pathway enrichment analysis was carried out for each functional module to identify potential biological pathways associated with genes in each module, and the threshold for significant pathway selection was false discovery rate (FDR) < 0.05.

Results

DEGs identification

Here, we obtained a total of 453 up-regulated and 225 down-regulated DEGs. As indicated in the clustering heat map (Fig. 1), these DEGs could well distinguish the IgAN and healthy samples completely.

Fig. 1
figure 1

Heat map of clustering analysis of gene expressions in different samples. X-axis represents samples, and Y-axis represents gene expressions

Full size image

Pathway enrichment analysis of the DEGs

Unfortunately, the up-regulated DEGs were not enriched in any pathways. However, the down-regulated DEGs were significantly enriched in nine pathways. The enriched pathways were listed in Table 1, including hematopoietic cell lineage (pathway, p-value = 7.92 × 10− 4; which involved interleukin-6 (IL6), tumor necrosis factor (TNF) and interleukin 1 beta (IL1B)), NOD-like receptor signaling pathway (pathway, p-value = 8.22 × 10− 3; which involved IL6, TNF and IL1B), cytokine-cytokine receptor interaction (pathway, p-value = 1.91 × 10− 2; which involved IL6, TNF, IL1B and C-C motif chemokine ligand 20 (CCL20)), intestinal immune network for IgA production (pathway, p-value = 2.52 × 10− 2; which involved IL6) and apoptosis (pathway, p-value = 2.58 × 10− 2; which involved TNF and IL1B).

Table 1 Pathway enrichment analysis of the down-regulated differentially expressed genes in monocytes of IgAN patients
Full size table

PPI network of the DEGs

As presented in Fig. 2, the PPI network with 379 nodes and 692 interactions was constructed. The hub nodes (whose degree > 10) mainly included TNF (degree = 31), PRKACA (degree = 26), IL6 (degree = 23), YWHAZ (degree = 19), MYB (degree = 15), TYK2 (degree = 14), FPR2 (degree = 13), IL1B (degree = 13), CCL20 (degree = 12), GNA11 (degree = 11).

Fig. 2
figure 2

Protein-protein interaction network of the differentially expressed genes. Circle in red denotes upregulated genes, and in green denotes downregulated genes

Full size image

Key nodes in the PPI network

Combined with the integrating results by four network centrality analyses, nodes with higher degree were used to cluster the two different kinds of samples. As a result, a total of 72 genes were identified that could well distinguish IgAN and healthy samples (Fig. 3). Among them, genes such as IL6, TNF, IL1B, PRKACA, TYK2 and CCL20 were closely related to five the pathways, including NOD-like receptor signaling pathway, cytokine-cytokine receptor interaction, hematopoietic cell lineage, apoptosis, and Toll-like receptor signaling pathway (Table 2).

Fig. 3
figure 3

Heat map of clustering analysis of key genes predicted by four network centrality analyses in different samples. X-axis represents samples, and Y-axis represents gene expressions

Full size image
Table 2 Enrichment analysis of hub genes in the protein-protein interaction network
Full size table

FI network analysis

The FI network of the DEGs was constructed utilizing ReactomeFI, which included 42 genes and 71 interaction edges (Fig. 4). Moreover, five modules (module a-e) were extracted from the FI network, and the absolute average correlation of genes in module a-e was 0.58, 0.4222, 0.5069, 0.4709 and 0.4275, respectively. Genes such as PRKACA in module a was enriched in integration of energy metabolism, morphine addiction and glutamatergic synapse pathways; in module b, genes such as CCL20, FPR2 and GNA11 were related to GPCR ligand binding, GPCR downstream signaling and Gastrin-CREB signaling pathway via PKC and MAPK pathways; in module c, the gene NFYB was highly associated with RNA binding-related pathways; while in module d, the gene HDAC10 was significantly enriched in two pathways, alcoholism and chromatin modifying enzymes (Table 3) . Genes in module e were not enriched in any pathways.

Fig. 4
figure 4

Gene functional interaction network of the differentially expressed genes. Circle in red denotes upregulated genes, and in green denotes downregulated genes

Full size image
Table 3 Enrichment analysis of genes in each functional interaction network module
Full size table

Notably, we found that 12 genes in the FI network also belonged to the hub genes, such as CCL20, FPR2, and PRKACA.

Discussion

In the present study, a total of 72 crucial nodes in the PPI network were identified via re-analyzing the dataset GSE58539, which could well distinguish the IgAN and healthy samples. Among which, genes such as IL6, TNF, IL1B, PRKACA, and CCL20 were closely related to the following pathways: NOD-like receptor signaling pathway, cytokine-cytokine receptor interaction, hematopoietic cell lineage, apoptosis and Toll-like receptor signaling pathway. Moreover, 12 genes in the FI network belonged to the 72 identified key nodes, such as CCL20, HDAC10, FPR2 and PRKACA. Besides, the 12 genes were also the key genes in 4 module networks correlating with pathways of integration of energy metabolism (module a), GPCR-related pathways (module b), RNA binding-related pathways (module c), alcoholism and chromatin modifying enzymes (module d).

The cytokine encoded by IL6 has great roles in inflammation and regulation of immune response [29]. Toll-like receptors (TLRs) are major factors that initiate the immune reaction. Most TLRs promote immune response (including innate and adaptive) via inducing expression of proinflammatory cytokines [30]. Increased TLRs, such as TLR-4, has been detected in circulating monocytes of patients with IgAN [31]. Expression of IL6 protein is also increased in mouse proximal tubular epithelial cells, accompanying by the upregulation of TLR4 mRNA [32]. IL1B, encoded by IL1B gene, is a member of interleukin 1 cytokine family and crucial for the regulation of inflammatory response [33]. In response to the external infections, gene expressions of the proinflammatory cytokines (e. g. IL1A, IL1B and IL6) are always upregulated simultaneously [34, 35]. In particular, IL1B is implicated in the TLR-4 induced immune response in chronic pain [36]. In our study, IL6 and IL1B were both downregulated and enriched in TLR signaling pathway. These results suggested that IL6 and IL1B might be co-regulated in TLR signaling pathway and contribute to the abnormality of the immune response in monocytes of IgAN patients.

TNF is a multifunctional proinflammatory cytokine. Reportedly, TNF expression is dramatically increased in Mycoplasma penetrans-infected IgAN mice model, and the protein is proposed to involve in the induction of renal damage in IgAN [37]. Moreover, levels of serum TNF receptors are also elevated in IgAN patients compared with healthy control [38]. However, Cox et al. uncover that TNF expression is obviously reduced in monocytes of IgAN patients, compared with those of HBDs [13]. The finding indicates the downregulated TNF may lead to the monocytes apoptosis. Moreover, the inhibition of TNF-α is proposed as a causative factor of IgAN [39]. Therefore, it might be speculated that the apoptosis of monocytes induced by downregulation of TNF contribute to IgAN progression.

CCL20 is a small cytokine that also involves in immune regulation and inflammation [40]. Combination of CCL20 with CCR6 (the CCL20 receptor) cause the recruitment of leukocyte subsets, which finally promote immune-mediated kidney damage [41]. Additionally, CCL20 is one of the chemokines that take part in the host response to pathogens invasions by activating inflammatory cells, and it has the similar effects on monocytes [42]. Therefore, the downregulated CCL20 in monocytes of IgAN patients might cause alteration in immune response, and thereby influence the IgAN development.

Three novel genes, protein kinase, CAMP-dependent, catalytic, alpha (PRKACA), formyl peptide receptor 2 (FPR2) and histone deacetylase 10 (HDAC10) were firstly predicted in monocytes of IgAN. PRKACA protein encoded by PRKACA gene is one subunit of protein kinase A that participates in apoptosis. At present, PRKACA amplification is served as a method for identifying genetic defect correlated with Cushing’s syndrome [43]. Somatic mutations of PRKACA have been detected in adenomas of the adrenal cortex [44]. Moreover, PRKACA mediates apoptosis-related signaling pathways in many cancer diseases, such as breast cancer and follicular thyroid cancer cells [45, 46]. In the present study, PRKACA was up-regulated and significantly enriched in apoptosis pathway, suggesting it might exert its function in monocytes via regulating apoptosis during IgAN progression. FPR2 is known to activate the G-protein coupled receptor and N-formyl peptide receptor. FPR2 is found in adipose tissues as a receptor for the pro-resolving mediators [47], which contribute to the restoration of in adipose inflammation and treatment of obesity-related glomerulopathy [48]. HDAC10, containing two catalytic sites, is highly expressed in numerous human tissues such as kidney [49]. In lung cancer, decreased HDAC10 is associated with the advanced stage and adverse outcome [50]. However, there are rare reports on the relationship of IgAN and HDAC10. In the current study, FPR2 and HDAC10 were hub up-regulated genes in both PPI network and FI network, implying they might co-function in monocytes of IgAN patients. One limitation of this study is the lack of expression validation. However, we will do more experiments to verify our conclusions once we collect the samples in the future.

Conclusions

In conclusion, several crucial genes were identified in monocytes of IgAN patients, such as IL6, TNF, IL1B, CCL20, PRKACA, FPR2 and HDAC10. They might have co-functions and their dysregulations might alter activities of pathways such as TLR and apoptosis signaling, which might finally promote IgAN progression. The study is of great value for the prediction of key regulators in monocytes of IgAN and the identification of targeting therapeutic management for IgAN.

Abbreviations

DCs:

Dendritic cells

DEGs:

Differentially expressed genes

FDR:

False discovery rate

FI:

Functional interaction

FPR2 :

Formyl peptide receptor 2

Gd-IgA1:

Galactose-deficient immunoglobulin A1

GEO:

Gene Expression Omnibus

HBDs:

Healthy blood donors

HDAC10 :

Histone deacetylase 10

IDs:

Identification numbers

IgAN:

Immunoglobulin A nephropathy

IL1B:

interleukin-1Beta

IL6 :

Interleukin-6

KEGG:

Kyoto encyclopedia of genes and genomes

LCA:

Leukocyte common antigen

PPI:

Protein-protein interaction

RMA:

Robust multi-array average

STRING:

Search tool for the retrieval of interacting genes

TLRs:

Toll-like receptors

TNF:

Protein Kinase, CAMP-Dependent, Catalytic, Alpha

TNF:

Tumor necrosis factor

References

  1. Nakanishi K, Yoshikawa N. Immunoglobulin a nephropathy. Springer Berlin Heidelberg. 2009;7(4):275–398.

  2. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin a nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrology. 2008;13(3):242–6.

    Article  PubMed  Google Scholar 

  3. Myllymäki J, Honkanen T, Syrjänen J, Helin H, Rantala I, Pasternack A, Mustonen J. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin a nephropathy. Kidney Int. 2007;71(4):343–8.

    Article  PubMed  CAS  Google Scholar 

  4. Kiryluk K, Novak J, Gharavi AG. Pathogenesis of immunoglobulin a nephropathy: recent insight from genetic studies. Annu Rev Med. 2013;64:339.

    Article  PubMed  CAS  Google Scholar 

  5. Novak J, Julian BA, Tomana M, Mestecky J. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Seminars in nephrology. 2008;28(1):78–87.

  6. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–14.

    Article  PubMed  CAS  Google Scholar 

  7. Mestecky J, Raska M, Julian BA, Gharavi AG, Renfrow MB, Moldoveanu Z, Novak L, Matousovic K, Novak J. IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol. 2013;8:217–40.

    Article  PubMed  CAS  Google Scholar 

  8. Tan Y, Zhang JJ, Liu G, Zhang H, Zhao MH. The level of urinary secretory immunoglobulin A (sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes. Clin Exp Immunol. 2009;156(1):111–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, Novak J, Gharavi AG, Wyatt RJ. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch–Schönlein purpura nephritis. Kidney Int. 2011;80(1):79–87.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Li G, Zhang H, Lv J, Hou P, Wang H. Tandem repeats polymorphism of MUC20 is an independent factor for the progression of immunoglobulin a nephropathy. Am J Nephrol. 2006;26(1):43–9.

    Article  PubMed  CAS  Google Scholar 

  11. Canaud G, Audard V, Kofman T, Lang P, Legendre C, Grimbert P. Recurrence from primary and secondary glomerulopathy after renal transplant. Transpl Int. 2012;25(8):812–24.

    Article  PubMed  CAS  Google Scholar 

  12. Coppo R, Camilla R, Alfarano A, Balegno S, Mancuso D, Peruzzi L, Amore A, Dal Canton A, Sepe V, Tovo P. Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int. 2009;75(5):536–41.

    Article  PubMed  CAS  Google Scholar 

  13. Cox SN, Serino G, Sallustio F, Blasi A, Rossini M, Pesce F, Schena FP. Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients. Nephrol Dial Transplant. 2015;30(7):1122–232.

    Article  PubMed  CAS  Google Scholar 

  14. Smyth GK. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor. 2005. p. 397–420.

  15. Dunning M, Lynch A, Eldridge M: illuminaHumanv4. db: Illumina HumanHT12v4 annotation data (chip illuminaHumanv4). R package version. 2013, 2(0).

  16. Gentleman R: annotate: Annotation for microarrays. R package version. 2003, 1(0):19.

  17. Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, Lumley T, Maechler M, Magnusson A, Moeller S: gplots: Various R programming tools for plotting data. R package version. 2009, 2(4).

  18. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44.

    Article  CAS  Google Scholar 

  19. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research. 2011;39(suppl_1):561–8.

  21. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431–2.

    Article  PubMed  CAS  Google Scholar 

  22. Latora V, Marchiori M. A measure of centrality based on network efficiency. New J Phys. 2007;9(6):188.

    Article  Google Scholar 

  23. Estrada E. Virtual identification of essential proteins within the protein interaction network of yeast. Proteomics. 2006;6(1):35–40.

    Article  PubMed  CAS  Google Scholar 

  24. Estrada E, Rodriguez-Velazquez JA. Subgraph centrality in complex networks. Phys Rev E. 2005;71(5):056103.

    Article  CAS  Google Scholar 

  25. Amitai G, Shemesh A, Sitbon E, Shklar M, Netanely D, Venger I, Pietrokovski S. Network analysis of protein structures identifies functional residues. J Mol Biol. 2004;344(4):1135–46.

    Article  PubMed  CAS  Google Scholar 

  26. Tang Y, Li M, Wang J, Pan Y, Wu F-X. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67–72.

    Article  PubMed  CAS  Google Scholar 

  27. Wu G, Dawson E, Duong A, Haw R, Stein L. ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis. F1000Research. 2014;3:146.

    PubMed  PubMed Central  Google Scholar 

  28. Röfer T, Jüngel M. Vision-based fast and reactive Monte-Carlo localization. In: IEEE international conference on robotics and automation: 2003: IEEE; 1999; 2003. p. 856–61.

    Google Scholar 

  29. Rossignol J, Boyer C, Thinard R, Remy S, Dugast AS, Dubayle D, Dey ND, Boeffard F, Delecrin J, Heymann D. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med. 2009;13(8b):2547–58.

    Article  PubMed  Google Scholar 

  30. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.

    Article  PubMed  CAS  Google Scholar 

  31. Coppo R, Camilla R, Amore A, Peruzzi L, Daprà V, Loiacono E, Vatrano S, Rollino C, Sepe V, Rampino T. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin a nephropathy. Clin Exp Immunol. 2010;159(1):73–81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Zhu X-L, Wang Y-J, Yang Y-Ζ, Yang R-C, Zhu B, Zhang YΗ, Lin Y, Lu Y, Li X-F, O'Byrne KT. Suppression of lipopolysaccharide-induced upregulation of toll-like receptor 4 by emodin in mouse proximal tubular epithelial cells. Mol Med Rep. 2012;6(3):493–500.

    Article  PubMed  CAS  Google Scholar 

  33. Dai D, Wang L, Xu L, Tang L, Xu X, Ye H, Zhou X, Chen C, Pan G, Ru P. A comprehensive meta-analysis of the association between three 1B polymorphisms and rheumatoid arthritis. Adv Biosci Biotechnol. 2014;5(2):108–16.

    Article  CAS  Google Scholar 

  34. Günther J, Esch K, Poschadel N, Petzl W, Zerbe H, Mitterhuemer S, Blum H, Seyfert H-M. Comparative kinetics of Escherichia coli-and Staphylococcus aureus-specific activation of key immune pathways in mammary epithelial cells demonstrates that S. aureus elicits a delayed response dominated by interleukin-6 (IL-6) but not by IL-1A or tumor necrosis factor alpha. Infect Immun. 2011;79(2):695–707.

    Article  PubMed  CAS  Google Scholar 

  35. Chen C-J, Ou Y-C, Lin S-Y, Raung S-L, Liao S-L, Lai C-Y, Chen S-Y, Chen J-H. Glial activation involvement in neuronal death by Japanese encephalitis virus infection. J Gen Virol. 2010;91(4):1028–37.

    Article  PubMed  CAS  Google Scholar 

  36. Guo L-H, Schluesener H. The innate immunity of the central nervous system in chronic pain: the role of toll-like receptors. Cell Mol Life Sci. 2007;64(9):1128–36.

    Article  PubMed  CAS  Google Scholar 

  37. Jiang X, Lv Y-Q, Zhang J-N, Shi Y-L, Xu F-F. Mycoplasma penetrans infection is a potential cause of immunoglobulin a nephropathy: a new animal model. J Nephrol. 2013;26:470–5.

    Article  PubMed  CAS  Google Scholar 

  38. Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. PLoS One. 2015;10(4):e0122212.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Wei S, Sinniah R. Adalimumab (TNFα inhibitor) therapy exacerbates IgA glomerulonephritis acute renal injury and induces lupus autoantibodies in a psoriasis patient. Case Reports Nephrol. 2013;2013(4):1–4.

  40. Starner TD, Barker CK, Jia HP, Kang Y, Jr MCP. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol. 2003;29(5):627.

    Article  PubMed  CAS  Google Scholar 

  41. Meng T, Li X, Ao X, Zhong Y, Tang R, Peng W, Yang J, Zou M, Zhou Q. Hemolytic Streptococcus may exacerbate kidney damage in IgA nephropathy through CCL20 response to the effect of Th17 cells. PLoS One. 2014;9(9):e108723.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Buonaguro L, Monaco A, Aricò E, Wang E, Tornesello ML, Lewis GK, Marincola FM, Buonaguro FM. Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation. BMC Bioinformatics. 2008;9(2):1.

    Google Scholar 

  43. Lodish MB, Yuan B, Levy I, Braunstein GD, Lyssikatos C, Salpea P, Szarek E, Karageorgiadis AS, Belyavskaya E, Raygada M. Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations. Eur J Endocrinol. 2015;172(6):803–11.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Beuschlein F, Fassnacht M, Assié G, Calebiro D, Stratakis CA, Osswald A, Ronchi CL, Wieland T, Sbiera S, Faucz FR. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N Engl J Med. 2014;370(11):1019–28.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Moody SE, Schinzel AC, Singh S, Izzo F, Strickland MR, Luo L, Thomas SR, Boehm JS, Kim SY, Wang ZC. PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling. Oncogene. 2015;34(16):2061–71.

    Article  PubMed  CAS  Google Scholar 

  46. Grosse J, Warnke E, Wehland M, Pietsch J, Pohl F, Wise P, Magnusson NE, Eilles C, Grimm D. Mechanisms of apoptosis in irradiated and sunitinib-treated follicular thyroid cancer cells. Apoptosis. 2014;19(3):480–90.

    Article  PubMed  CAS  Google Scholar 

  47. Clària J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol. 2012;189(5):2597–605.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Nolan E, O'Meara YM, Godson C. Lipid mediators of inflammation in obesity-related glomerulopathy. Nephrol Dial Transplant. 2013;28(suppl 4):iv22–9.

    Article  PubMed  CAS  Google Scholar 

  49. Tong JJ, Liu J, Bertos NR, Yang X-J. Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain. Nucleic Acids Res. 2002;30(5):1114–23.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol. 2009;9(4):375–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Yingbo Guo and Wenfeng Gao contributed equally to this work.

Authors and Affiliations

  1. Department of Nephropathy, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijng, 100078, China

    Yingbo Guo

  2. Department of Urology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijng, 100700, China

    Wenfeng Gao

  3. Department of Nephropathy and Endocrinology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No. 5 Haiyuncang, Dongcheng District, Beijng City, 100700, China

    Danyang Wang, Weijing Liu & Zhongjie Liu

Authors
  1. Yingbo Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenfeng Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Danyang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Weijing Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhongjie Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YG and WG designed the research and drafted the manuscript. ZL draft the manuscript and revised manuscript for important intellectual content. DW and WL acquired data, analyze data and Statistical analysis. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Zhongjie Liu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, Y., Gao, W., Wang, D. et al. Gene alterations in monocytes are pathogenic factors for immunoglobulin a nephropathy by bioinformatics analysis of microarray data. BMC Nephrol 19, 184 (2018). https://doi.org/10.1186/s12882-018-0944-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12882-018-0944-z

Keywords

  • Immunoglobulin a nephropathy
  • Network centrality analysis
  • Functional interaction
  • Toll-like receptor signaling
  • Apoptosis

BMC Nephrology

ISSN: 1471-2369

Contact us